Comprehensive Pathology Study Guide - Index Medical College Hospital and Research Centre

Shock: Classification, Pathogenesis of Septic Shock, and Complications

  • Classification of Shock

    • Shock is a state of systemic hypoperfusion caused by reduced cardiame. It is categorize

      • Hypovolemic Shock: Results from a severe loss of blood or fluid volume (e.g., hemorrhage, severe burns, dehydration).

      • Cardiogenic Shock: Caused by the failure of the myocardial pump (e.g., myocardial infarction, arrhythmias, cardiac tamponade).

      • Obstructive Shock: Results from physical obstruction to blood flow (e.g., pulmonary embolism).

      • Distributive Shock: Characterized by excessive vasodilation and impaired distribution of blood flow. This includes:

        • Septic Shock: Triggered by microbial infection.

        • Anaphylactic Shock: Triggered by severe allergic reactions.

        • Neurogenic Shock: Triggered by spinal cord injury or anesthetic accidents.

  • Pathogenesis of Septic Shock

    • Septic shock is most frequently caused by Gram-positive bacteria, followed by Gram-negative bacteria and fungi.

    • Inflammatory Mediators: Microbial components (like lipopolysaccharides in Gram-negative bacteria) activate neutrophils, macrophages, and endothelial cells.

    • Cytokine Storm: There is a massive release of pro-inflammatory cytokines, including TNF\text{TNF}, IL-1\text{IL-1}, IL-6\text{IL-6}, and IL-8\text{IL-8}. These cytokines promote systemic vasodilation and myocardial depression.

    • Endothelial Activation/Injury: This leads to a procoagulant state involving disseminated intravascular coagulation (DIC\text{DIC}) and increased vascular permeability, which results in tissue edema.

    • Metabolic Abnormalities: Sepsis impairs insulin signaling and promotes hyperglycemia. Furthermore, tissue hypoxia leads to lactic acidosis.

  • Complications of Shock

    • Multi-Organ Dysfunction Syndrome (MODS): Progressive failure of multiple organ systems.

    • Acute Respiratory Distress Syndrome (ARDS): Characterized by diffuse alveolar damage and refractory hypoxemia.

    • Acute Kidney Injury (AKI): Often manifesting as acute tubular necrosis due to ischemia.

    • Disseminated Intravascular Coagulation (DIC): Widespread microvascular thrombosis leading to consumption of clotting factors and subsequent hemorrhage.

    • Gastrointestinal Complications: Such as stress-induced mucosal ulcers (Curling or Cushing ulcers).

Classification of Anemia and Iron Deficiency Anemia

  • General Classification of Anemia

    • Morphological Classification: Based on Red Blood Cell (RBC\text{RBC}) indices like Mean Corpuscular Volume (MCV\text{MCV}):

      • Microcytic Hypochromic Anemia: MCV < 80\,\text{fL} (e.g., Iron Deficiency, Thalassemia, Sideroblastic anemia).

      • Normocytic Normochromic Anemia: MCV=80100fLMCV = 80-100\,\text{fL} (e.g., Acute blood loss, Hemolytic anemia, Anemia of chronic disease).

      • Macrocytic Anemia: MCV > 100\,\text{fL} (e.g., Vitamin B12\text{B}_{12} or Folate deficiency).

    • Etiological Classification: Based on the underlying cause:

      • Increased Destruction: Hemolytic anemias (hereditary or acquired).

      • Blood Loss: Acute (trauma) or Chronic (occult GI bleed).

      • Impaired Production: Deficiency of nutrients, bone marrow failure (aplastic anemia), or erythropoietin deficiency.

  • Iron Deficiency Anemia (IDA): Etiology

    • Increased Demand: Pregnancy and infancy.

    • Dietary Deficiencies: Malnutrition or strictly vegan diets.

    • Impaired Absorption: Celiac disease or gastrectomy.

    • Chronic Blood Loss: Most common cause in adults (e.g., peptic ulcers, hemorrhoids, menorrhagia, or GI malignancies).

  • Peripheral Smear Findings in IDA

    • The smear typically shows microcytic (small size\text{small size}) and hypochromic (\text{increased central pallor > 1/3 of the cell diameter}) RBCs.

    • Presence of Poikilocytosis (variation in shape), specifically pencil-shaped cells (elliptocytes) and target cells.

    • Anisocytosis (variation in size) is often reflected by an increased Red Cell Distribution Width (RDW\text{RDW}).

  • Laboratory Diagnosis of IDA

    • Hemoglobin (Hb): Reduced levels.

    • Serum Iron: Decreased levels.

    • Serum Ferritin: Decreased (this is the most sensitive marker for iron stores).

    • Total Iron Binding Capacity (TIBC): Increased.

    • Transferrin Saturation: Decreased (calculated as Serum IronTIBC×100\frac{\text{Serum Iron}}{\text{TIBC}} \times 100; usually below 15%15\% in deficiency).

    • Soluble Transferrin Receptor (sTfR): Elevated levels.

Myocardial Infarction: Case Presentation and Clinical Analysis

  • Case Profile

    • A 5858-year-old male presents with severe chest pain (substernal) radiating to the left arm for 4hours4\,\text{hours}.

    • Associated symptoms: Sweating (diaphoresis) and breathlessness (dyspnea).

    • Risk factors: Smoker, hypertensive, and diabetic.

    • Clinical signs: ST\text{ST} segment elevation on ECG\text{ECG}; elevated serum Troponin-I\text{Troponin-I}.

  • Diagnosis and Definition

    • Probable Diagnosis: Acute Myocardial Infarction (AMI\text{AMI}), specifically an ST\text{ST}-segment Elevation Myocardial Infarction (STEMI\text{STEMI}).

    • Definition: Myocardial Infarction is defined as the death of cardiac muscle (necrosis) due to prolonged severe ischemia.

  • Etiological Factors and Pathogenesis

    • Etiology: Includes atherosclerosis (the most common cause), tobacco smoking, hypertension, diabetes mellitus, hyperlipidemia, and family history.

    • Pathogenesis:

      1. Plaque Disruption: A pre-existing atherosclerotic plaque undergoes sudden change (rupture, erosion, or hemorrhage).

      2. Platelet Activation: Exposure of the subendothelial collagen and plaque contents triggers platelet adhesion, activation, and aggregation.

      3. Thrombosis: Activation of the coagulation cascade leads to the formation of an occlusive thrombus.

      4. Ischemia: Cessation of blood flow leads to aerobic metabolism failure, lactic acid accumulation, and eventually irreversible cell death if ischemia lasts beyond 2030minutes20-30\,\text{minutes}.

  • Morphological Features (Gross and Microscopic)

    • 4 to 12 Hours: Grossly, nothing is visible; microscopically, wavy fibers may appear at the periphery.

    • 12 to 24 Hours: Grossly, dark mottling; microscopically, coagulation necrosis and contraction band necrosis.

    • 1 to 3 Days: Grossly, mottled with a yellow-tan center; microscopically, heavy neutrophilic infiltrate.

    • 7 to 10 Days: Grossly, maximally soft with a depressed red-tan border; microscopically, phagocytosis of dead cells and early granulation tissue.

    • Over 2 Months: Grossly, well-developed gray-white scar; microscopically, dense collagenous scarring.

  • Investigations and Biomarkers

    • Biomarkers:

      • Troponin-I and Troponin-T: Most sensitive and specific; levels rise within 24hours2-4\,\text{hours} and remain elevated for 710days7-10\,\text{days}.

      • CK-MB: Rises in 24hours2-4\,\text{hours}, peaks at 24hours24\,\text{hours}, and returns to normal in 4872hours48-72\,\text{hours} (useful for detecting re-infarction).

    • Investigations: ECG\text{ECG} (showing ST\text{ST} elevation, T\text{T}-wave inversion, or pathological Q\text{Q} waves), Echocardiography, and Coronary Angiography.

  • Complications of AMI

    • Arrhythmias: Most common cause of death in the pre-hospital phase.

    • Contractile Dysfunction: Leading to Heart Failure or Cardiogenic Shock.

    • Myocardial Rupture: Occurs most commonly 37days3-7\,\text{days} post-infarction (e.g., ventricular wall rupture, septal rupture, or papillary muscle rupture).

    • Pericarditis: Fibrinous or fibrohemorrhagic (Dressler syndrome if late-onset).

    • Mural Thrombosis: Can lead to systemic embolism.

Cell Death: Apoptosis and Necrosis

  • Definitions

    • Apoptosis: A pathway of cell death induced by a tightly regulated intracellular program, where cells destined to die activate enzymes that degrade their own nuclear DNA and nuclear and cytoplasmic proteins (often called "programmed cell death").

    • Necrosis: A form of cell death resulting from severe acute injury, characterized by the denaturation of intracellular proteins and enzymatic digestion of the lethally injured cell.

  • Key Differentiators Between Apoptosis and Necrosis

    1. Cell Size: In apoptosis, the cell shrinks; in necrosis, the cell swells (oncosis).

    2. Nucleus: Apoptosis involves fragmentation into nucleosome-sized fragments; necrosis involves pyknosis, karyorrhexis, and karyolysis.

    3. Plasma Membrane: Remains intact in apoptosis (though structure is altered); it is disrupted/leaky in necrosis.

    4. Cellular Contents: Enzymatic digestion in necrosis often results in contents leaking out; in apoptosis, contents remain intact in apoptotic bodies.

    5. Adjacent Inflammation: Usually absent in apoptosis; frequently present in necrosis.

    6. Physiologic or Pathologic Role: Apoptosis is often physiologic (embryogenesis, hormone-dependent involution) but can be pathologic; necrosis is invariably pathologic.

Diabetes Mellitus: Vascular Complications

  • Macrovascular Complications

    • Accelerated Atherosclerosis of the large and medium-sized muscular arteries.

    • Myocardial Infarction: Most common cause of death in diabetics.

    • Stroke (Cerebrovascular Accident): Increased risk of ischemic brain injury.

    • Peripheral Vascular Disease: Leading to gangrene of the lower extremities.

  • Microvascular Complications

    • Diabetic Retinopathy: Leading cause of blindness; involves microaneurysms and neovascularization.

    • Diabetic Nephropathy: Characterized by basement membrane thickening and Kimmelstiel-Wilson lesions (nodular glomerulosclerosis), leading to chronic renal failure.

    • Diabetic Neuropathy: Most commonly a distal symmetric polyneuropathy ("glove and stocking" distribution).

Metabolic and Respiratory Pathology: Rickets and Asthma

  • Rickets

    • Etiopathogenesis: Caused by Vitamin D deficiency (dietary or lack of sunlight), malabsorption, or renal/liver disease interfering with Vitamin D metabolism. This results in impaired mineralization of the bone matrix (osteoid) and epiphyseal cartilage.

    • Pathological Features:

      • Craniotabes: Softening of the skull bones.

      • Rachitic Rosary: Expansion of the anterior rib ends at the costochondral junctions.

      • Harrison's Groove: Inward pulling of the ribs by the diaphragm.

      • Bowing of Legs: Due to the softening of weight-bearing long bones.

  • Bronchial Asthma

    • Definition: A chronic inflammatory disorder of the airways that causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, usually associated with widespread but variable bronchoconstriction and airflow limitation that is at least partly reversible.

    • Etiopathogenesis: Driven by a Type I hypersensitivity reaction involving IgE\text{IgE} and mast cell degranulation. It is characterized by airway hyper-responsiveness to various stimuli. Pathological changes include smooth muscle hypertrophy, mucous gland hyperplasia, and eosinophilic inflammation.

Gastrointestinal and Hepatobiliary Pathology

  • Peptic Ulcer Disease (PUD)

    • Etiopathogenesis: Primarily caused by infection with Helicobacter pylori\text{Helicobacter pylori} (H.pyloriH. pylori) or the chronic use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs\text{NSAIDs}). Other factors include hyperacidity (Zollinger-Ellison syndrome), smoking, and psychological stress.

    • Complications:

      • Hemorrhage: Most common complication; can lead to hematemesis or melena.

      • Perforation: Leads to peritonitis; often presents with air under the diaphragm on imaging.

      • Obstruction: Due to scarring and edema, particularly at the pyloric canal.

  • Jaundice

    • Definition: A yellowish discoloration of the skin, sclerae, and mucous membranes caused by hyperbilirubinemia (total serum bilirubin typically exceeding 2.02.5mg/dL2.0 - 2.5\,mg/dL).

    • Classification and Causes:

      • Pre-hepatic (Hemolytic): Excessive breakdown of RBCs (e.g., Sickle cell anemia, Malaria).

      • Hepatic (Hepatocellular): Liver cell damage or impaired conjugation (e.g., Viral Hepatitis, Cirrhosis, Gilbert syndrome).

      • Post-hepatic (Obstructive): Obstruction of the bile duct system (e.g., Gallstones, Carcinoma of the pancreas head).

General and Neoplastic Pathology

  • Wound Healing Factors

    • Local Factors: Infection (most important), foreign bodies, poor blood supply, and mechanical stress.

    • Systemic Factors: Nutrition (protein deficiency), Vitamin C\text{C} deficiency (collagen synthesis), Zinc deficiency, and glucocorticoid use (which inhibits inflammation and collagen synthesis).

  • FAB Classification of Acute Leukemia

    • French-American-British classification for Acute Myeloid Leukemia (AML\text{AML}):

      • M0\text{M}_0: Undifferentiated AML.

      • M1\text{M}_1: AML without maturation.

      • M2\text{M}_2: AML with maturation.

      • M3\text{M}_3: Acute Promyelocytic Leukemia (APL\text{APL}).

      • M4\text{M}_4: Acute Myelomonocytic Leukemia.

      • M5\text{M}_5: Acute Monocytic Leukemia.

      • M6\text{M}_6: Erythroleukemia.

      • M7\text{M}_7: Acute Megakaryoblastic Leukemia.

  • Benign vs. Malignant Neoplasms

    1. Differentiation: Benign are well-differentiated; malignant range from well-differentiated to undifferentiated (anaplastic).

    2. Rate of Growth: Benign is usually slow; malignant is generally rapid.

    3. Local Invasion: Benign tumors are cohesive and often encapsulated; malignant tumors infiltrate and destroy surrounding tissue.

    4. Metastasis: Benign tumors never metastasize; metastasis is a hallmark of malignancy.

    5. Mitotic Figures: Rare in benign; frequent and sometimes atypical in malignant.

    6. Nuclear:Cytoplasmic (N:C) Ratio: Normal in benign; increased in malignant.

  • Mediators of Inflammation

    • Vasoactive Amines: Histamine and Serotonin.

    • Arachidonic Acid Metabolites: Prostaglandins and Leukotrienes.

    • Cytokines: TNF\text{TNF}, IL-1\text{IL-1}, and Chemokines.

    • Plasma Protein Systems: Complement system, Kinin system, and the Coagulation/Fibrinolytic system.

  • Causes of Splenomegaly

    • Congestive: Portal hypertension (Cirrhosis) or Congestive Heart Failure.

    • Infectious: Malaria, Typhoid, Tuberculosis, or Infectious Mononucleosis.

    • Hematologic: Hemolytic anemias (hereditary spherocytosis), Thalassemia, or Polycythemia vera.

    • Infiltrative/Neoplastic: Leukemias, Lymphomas, or Gaucher disease.